EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Feasibility of reduced-dose cyclophosphamide plus etoposide for peripheral blood stem cell mobilization in patients with multiple myeloma and lymphoma: a prospective pilot study

Xuewu Zhang, Qiumei Yao, Xiang Zhang, Xinping Zhou, Gaixiang Xu, Liangshun You, Min Yang, Jiejing Qian, Haitao Meng, Wenjuan Yu, Jie Jin, Hongyan Tong

Annals of Hematology · 21.11.2026

DOI: 10.1007/s00277-026-07359-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 21.11.2026. Verfasst von Xuewu Zhang und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhang, X., Yao, Q., Zhang, X., Zhou, X., Xu, G., You, L., Yang, M., Qian, J., Meng, H., Yu, W., Jin, J., & Tong, H. (2026). Feasibility of reduced-dose cyclophosphamide plus etoposide for peripheral blood stem cell mobilization in patients with multiple myeloma and lymphoma: a prospective pilot study. Annals of Hematology. https://doi.org/10.1007/s00277-026-07359-5

Vancouver

Zhang X, Yao Q, Zhang X, Zhou X, Xu G, You L, et al. Feasibility of reduced-dose cyclophosphamide plus etoposide for peripheral blood stem cell mobilization in patients with multiple myeloma and lymphoma: a prospective pilot study. Annals of Hematology. 2026. doi:10.1007/s00277-026-07359-5

BibTeX
@article{Zhang2026,
  author = {Zhang, Xuewu and Yao, Qiumei and Zhang, Xiang and Zhou, Xinping and Xu, Gaixiang and You, Liangshun and Yang, Min and Qian, Jiejing and Meng, Haitao and Yu, Wenjuan and Jin, Jie and Tong, Hongyan},
  title = {Feasibility of reduced-dose cyclophosphamide plus etoposide for peripheral blood stem cell mobilization in patients with multiple myeloma and lymphoma: a prospective pilot study},
  journal = {Annals of Hematology},
  year = {2026},
  doi = {10.1007/s00277-026-07359-5}
}
Kostenlos starten →